ReviewCurrent urology reports2026
Advancements in Single-Port Robotic Urologic Surgery: A Comprehensive Review of Contemporary Innovations and Outcomes.
Review in Current urology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewSingle-port robotic surgery has experienced remarkable evolution over the past five years, fundamentally transforming minimally invasive urologic practice. This review examines recent advancements in single-port robotic platforms, surgical techniques, and clinical outcomes across the spectrum of urologic procedures. RECENT
findingsThe introduction of the da Vinci SP surgical system and emerging competitors has catalyzed innovation in urologic surgery. Novel approaches including Retzius-sparing radical prostatectomy, extraperitoneal access techniques, transvesical simple prostatectomy, partial nephrectomy, ureteral reconstruction, and pyeloplasty have demonstrated comparable oncologic and functional outcomes to conventional multiport approaches while potentially offering enhanced cosmesis, reduced postoperative pain, and faster recovery. Single-port robotic urologic surgery has matured significantly, with accumulating evidence supporting its safety, feasibility, and efficacy while utilizing novel surgical approaches. Continued refinement of surgical techniques, expanding platform availability, and growing surgeon experience are driving broader adoption. This review synthesizes contemporary literature to guide clinical practice and identify future research priorities.
Indexed as
Identifiers
42726331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.